Biodesix, Inc.
BDSX
$0.549
-$0.0046-0.83%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 39.28% | 34.54% | 50.99% | 63.63% | 52.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.28% | 34.54% | 50.99% | 63.63% | 52.68% |
| Cost of Revenue | 28.69% | 29.42% | 19.73% | 0.19% | 2.06% |
| Gross Profit | 42.44% | 36.15% | 62.71% | 97.77% | 79.24% |
| SG&A Expenses | 24.42% | 29.17% | 18.07% | 8.25% | -2.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.38% | 29.42% | 14.46% | 1.42% | -8.44% |
| Operating Income | 4.38% | -19.79% | 25.23% | 33.02% | 50.71% |
| Income Before Tax | 9.72% | 6.31% | 19.08% | 27.21% | 55.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.72% | 6.31% | 19.08% | 27.21% | 55.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.72% | 6.31% | 19.08% | 27.21% | 55.06% |
| EBIT | 4.38% | -19.79% | 25.23% | 33.02% | 50.71% |
| EBITDA | 13.15% | -11.10% | 33.37% | 38.77% | 54.83% |
| EPS Basic | 43.13% | 48.98% | 50.03% | 41.75% | 71.86% |
| Normalized Basic EPS | 43.76% | 49.01% | 51.46% | 41.97% | 65.12% |
| EPS Diluted | 43.13% | 48.98% | 50.03% | 41.75% | 71.86% |
| Normalized Diluted EPS | 43.76% | 49.01% | 51.46% | 41.97% | 65.12% |
| Average Basic Shares Outstanding | 58.79% | 83.54% | 61.99% | 24.95% | 59.72% |
| Average Diluted Shares Outstanding | 58.79% | 83.54% | 61.99% | 24.95% | 59.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |